BS EN ISO 14708-4:2022
$198.66
Implants for surgery. Active implantable medical devices. – Implantable infusion pump systems
Published By | Publication Date | Number of Pages |
BSI | 2022 | 70 |
This document specifies particular requirements for active implantable medical devices intended to deliver a medicinal substance to site-specific locations within the human body, to provide basic assurance of safety for both patients and users. It amends and supplements ISO 14708-1:2014. The requirements of this document take priority over those of ISO 14708-1. This document is applicable to active implantable medical devices intended to deliver medicinal substances to site-specific locations within the human body. This document is also applicable to some non-implantable parts and accessories of the devices defined in Clause 3. The tests that are specified in this document are type tests intended to be carried out on a sample of a device to show compliance and are not intended to be used for the routine testing of manufactured products. NOTE This document is not intended to apply to non-implantable infusion systems.
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | undefined |
4 | European foreword Endorsement notice |
7 | Foreword |
9 | Introduction |
11 | 1 Scope 2 Normative references 3 Terms and definitions |
13 | 4 Symbols and abbreviated terms 5 General requirements for active implantable medical devices 5.1 General requirements for non-implantable parts 5.2 General requirements for software 5.3 Usability of non-implantable parts 5.4 Data security and protection from harm caused by unauthorized information tampering 5.5 General requirements for risk management 5.6 Misconnection of parts of the active implantable medical device 6 Requirements for particular active implantable medical devices 6.1 Implantable infusion pump system specifications |
14 | 6.2 Septum puncture test |
15 | 7 General arrangement of the packaging 8 General markings for active implantable medical devices |
16 | 9 Markings on the sales packaging 10 Construction of the sales packaging |
17 | 11 Markings on the sterile pack 12 Construction of the non-reusable pack 13 Markings on the active implantable medical device 14 Protection from unintentional biological effects caused by the active implantable medical device |
18 | 15 Protection from harm to the patient or user caused by external physical features of the active implantable medical device 16 Protection from harm to the patient caused by electricity 17 Protection from harm to the patient caused by heat |
19 | 18 Protection from ionizing radiation released or emitted from the active implantable medical device 19 Protection from unintended effects caused by the active implantable medical device |
20 | 20 Protection of the active implantable medical device from damage caused by external defibrillators 21 Protection of the active implantable medical device from changes caused by high-power electrical fields applied directly to the patient 22 Protection of the active implantable medical device from changes caused by miscellaneous medical treatments 22.1 Diagnostic ultrasound 22.2 Magnetic resonance imaging |
21 | 23 Protection of the active implantable medical device from mechanical forces |
22 | 24 Protection of the active implantable medical device from damage caused by electrostatic discharge 25 Protection of the active implantable medical device from damage caused by atmospheric pressure changes 26 Protection of the active implantable medical device from damage caused by temperature changes 27 Protection of the active implantable medical device from electromagnetic non-ionizing radiation 27.1 General |
23 | 27.2 Test conditions 27.2.1 Acceptance criteria 27.2.2 Test configuration 27.2.3 Operating functions, modes, and settings 27.3 Documentation |
24 | 27.4 Protection from static magnetic fields of flux density up to 50 mT |
25 | 27.5 Protection from magnetic fields over the frequency range 16 Hz to 26 MHz |
26 | 27.6 Protection from EM disturbances over the frequency range 80 MHz to 2,7 GHz |
27 | 27.7 Protection from proximity fields due to RF wireless communications equipment |
28 | 27.8 Optional characterization testing 28 Accompanying documentation |
31 | Annex A (informative) Relationship between the fundamental principles in ISO/TR 14283 and the clauses of this document |
52 | Annex B (informative) Rationale |
61 | Annex C (informative) Guidance on the allocation of requirements to non-implantable parts connected to a power source |
68 | Bibliography |